Further studies investigating the presence of such promising biomarkers in circulating exosomes expressing the astrocyte-linked glutamate aspartate transporter (GLAST) will open new perspectives for predicting ALS and monitoring ALS patients and their sub-populations in a non-invasive manner. This evidence concerns the gene SLC1A3 and amyotrophic lateral sclerosis.